Kintara Therapeutics Inc (KTRA)

[jssdmm]

I will just hold and pick up small lots at low prices like now.

CEO and CFO both bought open market recently.

I think you're making a good call though. No real catalysts before then. But there will be some interim data they can present on the Phase 2 trials in November. Any peek will be interesting. The good thing is they have more than enough funding to see the Phase 3 trial to completion now. You never know when it can jump though. It can easily be a $300 million dollar market cap before end of trial...but its $20. Oh well.

I don't see any red flags at all though. And the opportunity to offer a new, more effective (for certain known patients) frontline chemotherapy across GBM, lung and ovarian is tremendous.

I'm a patient guy, thank goodness.